Latest Humane Genomics News & Updates

Humane Genomics updates selective replication progress

They implemented ON-switch aptazymes for precise control of RNA virus replication in cancer cells, showing high selectivity and safety in experiments.

Humane Genomics announces manufacturing partnership with Genezen

They will transfer process and produce cGMP batches of their lead oncolytic virus candidate for hepatoblastoma to support toxicology and future FIH trials.

Humane Genomics announces move to Alexandria LaunchLabs

The organization relocated its lab to a new innovation space to enhance research and collaboration in cancer therapy development.

Humane Genomics showcases oncolytic viral therapy data at AACR 2025

The post highlights preclinical findings of HGI627, a targeted therapy for pediatric liver cancer, presented at the AACR annual meeting in Chicago.

Genezen Partners with Elly’s Team on Development for AAV Serotype 9 Gene Replacement Therapy for NEDAMSS; Genezen CTO Dr. Susan D’Costa to join nonprofit’s board

Indianapolis, IN and New York, NY, – November 12, 2025 – Genezen, a leading viral vector Contract Development and Manufacturing Organization (CDMO), and Humane Genomics...

Humane Genomics Raises Seed Funding

Meet Scientist Andrew Hessel, a Surfer Riding the Waves of Innovation in Synthetic Biology

As founder of the Pink Army Cooperative, and Humane Genomics, Inc., he aims to explore rewiring or reprogramming organisms to do jobs they can't do...

Humane Genomics is 3D-printing oncolytic viruses to treat rare cancers